Hypertension
From the Journals
Statins again linked to lower COVID-19 mortality
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t...
Conference Coverage
What’s best for diabetes after metformin? GRADE outdated at outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, but the study is already outdated, said one...
Conference Coverage
Bariatric surgery leads to better cardiovascular function in pregnancy
The cardiovascular benefits of bariatric surgery include reduced hypertension, remodeling of the heart with a reduction in left ventricular mass,...
From the Journals
Stopping statins linked to death, CV events in elderly
A new study suggests that eliminating statins for elderly patients with polypharmacy may have negative effects that far outweigh any benefits.
Conference Coverage
Bariatric surgery tied to 22% lower 5-year stroke risk
This study contributes to knowledge that suggests that reduction in ischemic stroke risk is yet another benefit of bariatric surgery, says a study...
Conference Coverage
Medically suspect criterion can determine bariatric surgery coverage
From the Journals
Healthy with obesity? The latest study casts doubt
Analysis from the U.K. Biobank finds that persons with “metabolically healthy obesity” still have increased risks for several adverse outcomes,...
Conference Coverage
Bariatric surgery tied to fewer HFpEF hospitalizations
From the Journals
Eat two fruits a day, ward off diabetes?
Results from an observational study “support encouragement of the consumption of whole fruits, but not fruit juice, to preserve insulin...
Guidelines
AHA: Physical activity best first-line for high BP, cholesterol
Advice to sit less and move more is a critical component of first-line treatment for patients with mild to moderate hypertension and elevated...
From the Journals
A1c below prediabetes cutoff linked to subclinical atherosclerosis
Hemoglobin A1c below prediabetes levels is a potential biomarker for subclinical atherosclerosis, a European observational study reports.